PCF Virtual 21st Pharma & Med Device Ethics & Compliance Congress Content Now Available Online and via Flash Drive
  • Virtual Online Video Event Live and 6 Months Access to Video Archive
  • Sponsored by the Pharmaceutical Compliance Forum
  • Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
  • Congress Held November 4 - 6, 2020
  • www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com

THE VIRTUAL TWENTY-FIRST PHARMA/MEDICAL DEVICE CONGRESS CONTENT IS NOW AVAILABLE FOR PURCHASE

The Virtual Twenty-First Pharmaceutical/Medical Device Congress conference content is now available for purchase via online archive access (6 months) and Flash Drive.

Online Archive or Flash Drive of the Virtual Twenty-First Pharmaceutical/Medical Device Congress Presentations!

Online Archive of Virtual Twenty-First Pharmaceutical/Medical Device Congress Presentations!
Complete conference: $195
Order Now
Flash Drive of Virtual Twenty-First Pharmaceutical/Medical Device Congress Presentations!
$195
Order Now


WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- NOVEMBER 24, 2020: The 21st Anniversary Pharmaceutical and Medical Device Compliance Congress, www.PharmaCongress.com, took place November 4 - 6, 2020 as a fully virtual event. The conference video content is now available for purchase.

VIRTUAL CONGRESS HIGHLIGHTS
  • New content, optimized for online learning
  • Focused on new regulatory developments
  • Managing ethics and compliance programs during the COVID 19 pandemic
  • Engage through polling, Q&A sessions, chat and direct video messaging
  • Network in real time with other attendees through direct attendee to attendee and group video messaging
  • Live and curated sessions streamed directly to you through our easy to navigate virtual platform
  • Access to an extensive video archive of past Congress presentations
  • Virtual exhibit hall featuring innovative solutions, products and services

KEYNOTE SPEAKERS

Craig Carpenito, JD
United States Attorney, US Attorney’s Office, District of New Jersey; Former Senior Counsel, Northeast Regional Office, US Securities and Exchange Commission; Newark, NJ
Gregory E. Demske, JD
Chief Counsel to the Inspector General Office of Inspector General, US Department of Health and Human Service, Washington, DC
Susan Dentzer
Visiting Fellow, Duke-Margolis Center for Health Policy; Former Editor in Chief, Health Affairs; Former Health Correspondent, PBS NewsHour; Washington, DC

Robert I. Dodge, JD
Assistant Director, FCPA Unit, US Securities & Exchange Commission; Former Assistant U.S. Attorney, US Attorney’s Office, Western District of Michigan; Former Assistant Section Chief, Environmental Defense Section, US Department of Justice; Washington, DC
Robert W. Dubois, MD, PhD
Interim President and CEO, National Pharmaceutical Council (NPC); Former Chief Medical Officer, Cerner LifeSciences; Washington, DC
Gustav W. Eyler, JD
Director, Consumer Protection Branch, Civil Division, US Department of Justice, Washington, DC

Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion (OPDP), US Food and Drug Administration, Silver Spring, MD
Matthew J. Lash, JD
Assistant Director, Consumer Protection Branch, US Department of Justice, Washington, DC
David Last, JD
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

Andy Mao, JD
Deputy Director, Fraud Section, Civil Division, Elder Justice Initiative Coordinator, US Department of Justice, Washington, DC
Dan Mendelson, MPP
Founder, Avalere Health, Operating Partner, Welsh, Carson, Anderson & Stowe, Board, Centrexion Therapeutics Corp., Washington, DC
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC

Gregg Shapiro, JD
Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, US Department of Justice, Boston, MA
Amanda Masselam Strachan, JD
Assistant US Attorney and Chief, Health Care Fraud Unit, US Attorney’s Office, District of Massachusetts, US Department of Justice, Boston, MA
Edie Stringfellow, MS
Director, Diversity & Inclusion, Massachusetts Biotechnology Council, Cambridge, MA

CO CHAIRS

Indrani Franchini, JD
Executive Vice President Chief Compliance Officer, Alexion Pharmaceuticals, New York, NY
Jeffrey M. Kawalek, MBA
Deputy Chief Compliance Officer, Jazz Pharmaceuticals, Inc., Chair, Pharmaceutical Compliance Forum (PCF), Philadelphia, PA (PCF Chair)
Margaret Sparks, JD
Head of Compliance, Vaccines, North America Ethics and Business Integrity, Sanofi, Bridgewater, NJ (PCF Co-Chair)

Ann Marie Tejcek
Senior Director, Chief Compliance Officer North America, Eli Lilly, Indianapolis, IN (PCF Co-Chair)
Donna White, CCEP
Vice President, Compliance, Chiesi, Cary, NC (PCF Co-Chair)
Joe Zimmerman
Vice President, Chief Compliance Officer & Privacy Officer, Ferring Pharmaceuticals, Inc., Parsippany, NJ (PCF Co-Chair)

FEATURING THE ANNUAL INVITATION-ONLY CHIEF COMPLAINCE OFFICER ROUNDTABLE
November 4, 2020; Invitation-only; No Cost. CCOs interested in attending may contact Debra Scanlon, Administrator, Pharmaceutical Compliance Forum at info@pharmacomplianceforum.org.
AdvaMed UPDATE

Christopher L. White, JD
Chief Operating Officer & General Counsel, Advanced Medical Technology Association (AdvaMed), AdvaMed COVID Action Team Leader, Washington, DC
PhRMA UPDATE

Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services (HHS); Washington, DC
OIG ANALYTICS/AI UPDATE

Renata Maziarz Miskell, MPS
Acting Chief Data and Analytics Officer, Office of Inspector General (OIG), US Department of Health and Human Services, Washington, DC
DOJ SPEAKER PROGRAMS UPDATE

Jake Lillywhite, JD
Assistant US Attorney, Civil Division, US Attorney's Office, Southern District of New York, US Department of Justice, New York, NY

FEATURING THE ANNUAL CHIEF COMPLIANCE OFFICER FIRESIDE CHAT WITH

Dennis K. Barnes, JD CPA
Vice President, Global Governance, Risk & Compliance, Mayne Pharma; Former Vice President, Compliance & Risk Management, Global Compliance Officer, PAREXEL International; Raleigh-Durham, NC
Mark Graves, JD, MBA
Senior Vice President and Chief Compliance Officer, MiMedx; Former Director, Global Patient Experience & Value, UCB; Former Senior Director, Pharmaceutical Products Division, Abbott; Marietta, GA
Nancy A. Grygiel, JD
Senior Vice President, Chief Compliance Officer, Amgen; Former VP Compliance, Corporate & International, Allergan; Former Senior Director Global Compliance, Mylan; Newbury Park, CA

John Knighton, JD
Chief Compliance Officer, TherapeuticsMD; Former Vice President, Head of Global Compliance, Orexigen Therapeutics; Boca Raton, FL
Tara R. Shewchuk, JD, LLM
Chief Deputy Ethics and Compliance Officer, Medtronic; Former Senior Director, Ethics and Compliance, Abbott (now AbbVie); Former VP, Chief Compliance, Privacy & Security Officer, Resurrection Health Care (now Ascension/AMITA); Minneapolis, MN
Tom Gregory, MBA
Global & US Leader, Health & Life Sciences, Forensic & Integrity Services, EY, Atlanta, GA (Moderator)

AND A ROUNDTABLE ON IMPLEMENTING EQUITY, DIVERSITY AND INCLUSION BY

Michael R. Clarke, JD, CCEP
Vice President, Global Chief Compliance Officer, ConvaTec; Former VP, Corporate Compliance, Indivior; Former VP, Ethics & Compliance, Americas, Actavis; Former VP & Compliance Officer, Biomet Spine & Bone Healing Technologies; Bridgewater, NJ
Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries; Former VP Healthcare Compliance & Privacy, Johnson & Johnson; Former Global Chief Compliance Officer and Corporate VP, Biomet; Chicago, IL
Jill Fallows Macaluso, JD
Corporate Vice President, Chief Ethics, Compliance & Privacy Officer, Novo Nordisk, Princeton, NJ

Robert A. Ladd, JD
Vice President, Global Head Integrity & Compliance, Novartis, Oncology; Former General Counsel, GE Healthcare; Former Global Head of Compliance Training, Goldman Sachs; Former Senior Corporate Counsel, Pfizer; New York, NY
Latarsha Stewart, JD, MS
Vice President, Head of Compliance, Servier Pharmaceuticals; Former Head of Compliance, Global Oncology Business Unit, Takeda Oncology; Boston, MA


SPONSORED BY

The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 80+ distinguished researched-based pharmaceutical manufacturers and biotech companies. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effect corporate compliance programs.


CONTINUING EDUCATION CREDITS
Compliance Professionals: Pending approval to offer Compliance Certification Board (CCB)® credits.

Click here for more information.
MEDIA PARTNERS:






GRANTORS:
GOLD


SILVER








BRONZE




































VIRTUAL CONGRESS HIGHLIGHTS
  • New content, optimized for online learning

  • Focused on new regulatory developments

  • Managing ethics and compliance programs during the COVID 19 pandemic

  • Engage through polling, Q&A sessions, chat and direct video messaging

  • Network in real time with other attendees through direct attendee to attendee and group video messaging

  • Live and curated sessions streamed directly to you through our easy to navigate virtual platform

  • Access to an extensive video archive of past Congress presentations

  • Virtual exhibit hall featuring innovative solutions, products and services

    • STAY CONNECTED


    Tweet using #PharmaCongress

    FEATURED FACULTY

    Sergio Juan Abreu
    Regional Compliance Officer, APAC, Merck Group; Former Regional Compliance Officer – LATAM, Merck Serono; Singapore
    Peter Agnoletto, CPA
    Compliance Officer, Primary Care and Consumer Health Care, Sanofi; Former Chief Compliance Officer & Chief Audit, Executive & ERM Leader, Par Pharma; Flemington, NJ
    Khelin N. Aiken, JD
    Partner, Baker & McKenzie LLP; Former Regulatory Counsel, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), Washington, DC
    Sergio Alegre, JD
    Vice President, Global Compliance, Osmotica; Former Executive Director Compliance, Pacira; Bridgewater, NJ
    Punkaj T. Amin, MBA, CFE
    Compliance Officer - US Wound Management,Office of Ethics and Compliance (OEC), Smith & Nephew; Former Director, Communications & Public Relations - North America, Grifols; Fort Worth, TX

    Bill Aprea, JD
    Former Executive Director, Senior Franchise and Compliance Counsel, JD; Celgene/Bristol-Myers Squibb; Chatham, NJ
    Madelyn Archibald
    Compliance Education and Training Manager, Merz Aesthetics, Raleigh, NC
    Melia Arnett-Archie, JD
    Senior Privacy & Data Protection Counsel, Stryker; Former Assistant State Attorney, Miami-Dade State Attorney’s Office; Fort Lauderdale, FL
    Samantha Barrett Badlam, JD
    Counsel, Litigation and Enforcement Group, Ropes & Gray, Washington, DC
    Yogesh Bahl, CPA, MBA
    Managing Director, AlixPartners New York, NY

    Ann E. Beasley, JD
    Director, Life Sciences, Governance, Risk & Compliance, Guidehouse; Former Senior Vice President, Chief Compliance Officer, Biogen; Boston, MA
    John T. Bentivoglio, JD
    Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC
    Richard Bistrong, MA
    Chief Executive Officer, Front-Line Anti-Bribery LLC, Contributing Editor, FCPA Blog; Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ; Former Cooperating Witness, City of London Police, HMRC and CPS, UK; New York, NY
    Craig Bleifer, JD
    Principal, Craig B. Bleifer, LLC; Former Corporate Vice President, General Counsel North America, Novo Nordisk; Former Senior Vice President, General Counsel and Secretary, Daiichi Sankyo; Summit, NJ
    Eric Bolesh
    Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC

    Terra Buckley, JD
    Vice President, Head of Global Compliance, Mesoblast Limited; Former Executive Director, Head of the Business Advisory Center of Excellence, US Healthcare Compliance, Celgene; New York, NY
    Shelby Buettner, JD
    Associate Chief Counsel, Office of the Chief Counsel Food and Drug Administration, Washington, DC
    Joseph Calarco
    Vice President, Compliance, Nabriva Therapeutics; Former Chief Compliance Officer, NEOS Therapeutics; Former Director, Compliance & Ethics, US Operations, Bristol-Myers Squibb; Lansdale, PA
    Christie Camelio
    Chief Compliance, Ethics & Risk Management Officer, TG Therapeutics; Former Vice President, Deputy Global Chief Compliance Officer, Celgene; New York, NY
    Cynthia Cetani
    Chief Integrity & Compliance Officer, Indivior; Former Group Integrity & Compliance, Head, Compliance Operations, Novartis International AG; Richmond, VA

    Parth Chanda, JD, MPA
    Founder and CEO, Lextegrity; Former Chief Compliance Counsel, Oncology, Pfizer; New York, NY
    Katherine Chaurette, MS, JD
    Vice President Healthcare Law and Compliance, Blueprint Medicines; Former Sr. Director, Regulatory and Commercial Law, Regeneron; Former VP, Legal, Head of Health Law, Regulatory, Market Access, Marketed and Launch Products, Sanofi; Jamaica Plain, MA
    Masha Chestukhin, MSJ
    Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme; Former Senior Manager NA Compliance, Sanofi; Jamaica Plain, MA
    Yvonne Clark, JD
    Corporate Compliance Counsel, Spark Therapeutics; Former Commercial Counsel, Merck; Philadelphia, PA
    Thomas Costa, JD
    Member, US Board of Directors, Sanofi; Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb; Washington, DC

    Clarissa Crain
    Senior Manager, Deloitte; Former Analyst, Commercial Operations, Cephalon; Philadelphia, PA
    Emily Cunningham
    Associate Principal, Compliance Consulting, IQVIA, New York, NY
    Meenakshi Datta, JD
    Partner and Global Co-leader, Healthcare Practice, Sidley Austin LLP, Chicago, IL
    BJ D'Avella, MBA
    Leader, Life Sciences Consulting Group, Paul Hastings, New York, NY
    Ethan Davis, JD
    Partner King & Spalding LLP; Former Acting Assistant Attorney General, Civil Division, US, Department of Justice; Washington, DC

    Noël Denice, JD
    Legal Counsel, Philips North America, LLC; Former Assistant General Counsel, Olympus Scientific Solutions Americas; Boston, MA
    Anisa Dhalla
    Global Chief Compliance Officer, UCB, Inc., Atlanta, GA
    Sarah diFrancesca, JD
    Partner, Dinsmore & Shohl LLP, Cincinnati, OH
    Stefanie A. Doebler, JD
    Of Counsel and Co-chair, Health Care Practice Group, Covington & Burling LLP, Washington, DC
    Tara D'Orsi, JD
    Executive Vice President, Chief Compliance Officer and General Counsel, Kyowa Kirin North America; Former Senior Counsel, Reliant Pharmaceuticals; New York, NY

    J. Mark Farrar, MSJ, CPA, CFE, CFF, CIPP/US
    Partner, Life Sciences Governance, Risk Management and Compliance, Guidehouse; Former Interim Chief Global Compliance Officer, Beckman Coulter; Atlanta, GA
    Margaret Feltz, MA, JD
    Vice President, Ethics & Compliance, Purdue Pharma; Former Compliance Counsel, Boehringer Ingelheim; Stamford, CT
    Christine Fiore, MBA
    Executive Director, Ethics and Commercial Compliance, Boehringer Ingelheim; Former Group Director Ethics and Compliance, Smith & Nephew; Ridgefield, CT
    Hollie K. Foust, JD
    Senior Vice President, Legal and Compliance, Cardinal Health,Dublin, OH
    Nereyda Garcia, JD
    Compliance Head, Rare Disease and Rare Blood Disorder, Sanofi; Former Global Head, Ethics and Compliance, Alnylam; Former Sr. Director, Compliance, Biogen Idec; Boston, MA

    Mark Gardner, MBA, JD
    Managing Attorney, Gardner Law, PLLC; Adjunct Professor, Drug & Device Law, Mitchell Hamline School of Law; Stillwater, MN
    Gary F. Giampetruzzi, Esq.
    Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY
    Thomas M. Glavin, JD
    Chief Compliance Officer for the Americas, Olympus Corporation of the Americas; Former Vice President, US/Americas Compliance Officer, Shire; Center Valley, PA
    Jonathan Glazier, MBA, JD
    Head of Legal Compliance, Philips North America; Former Sr Director of Corporate Compliance and Privacy Officer, Fresenius Medical Care North America; Andover, MA
    Betania Glorio, LLM
    Global Compliance Officer, Healthcare, Merck KGaA; Former Senior Director, Legal and Compliance EMEA, Horizon, Raptor and Onyx; Darmstadt, Germany

    Gejaa T. Gobena, JD
    Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division; Former Trial Attorney, Civil Division, Fraud Section, US Department of Justice; Washington, DC
    Thomas Goimarac, MBA, CHFP
    Managing Consultant, Berkeley Research Group, LLC (BRG), Phoenix, AZ
    Christine Gordon, JD
    Deputy Chief Compliance Officer, Olympus Corporation of the Americas; Former Assistant District Attorney, Philadelphia District Attorney’s Office; Bethlehem, PA
    Adam Greene, JD, MPH
    Partner and Co-chair, Health Information & HIPAA Practice, Davis Wright Tremaine LLP; Former Senior Health Information Technology and Privacy Specialist, Office for Civil Rights, HHS; Washington, DC
    Amy J. Greer, JD
    Partner, Baker & McKenzie LLP; Former Regional Trial Counsel (Philadelphia), US Securities and Exchange Commission; New York, NY

    Ethan Gumpert
    Global Ethics, Compliance and Governance, Advanced Medical Technology Association (AdvaMed), Washington, DC
    Jeffrey Hagy
    Associate Director, Corporate Compliance, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
    Saul B. Helman, MD, MBA
    Partner, Life Sciences Functional Practice Leader, Guidehouse; Former Director, Eli Lilly; Zionsville, IN
    Michael Hercz, JD
    Senior Vice President and General Counsel, Sentynl; Former Vice President, Law & Chief Compliance Officer, Victory Pharma; Former Executive Director, Enterprise Risk Management, Amgen; Solana Beach, CA
    Susan K. Hibbard
    Associate Director, Transparency Office of Ethics & Compliance, Boehringer Ingelheim, Ridgefield, CT

    Casey J. Horton, CFE
    Director, Life Sciences, Governance, Risk & Compliance, Guidehouse, Chicago, IL
    Emily Huebener, MA
    Senior Manager, Health and Life Sciences Forensic & Integrity Services, EY, Chicago, IL
    Briannon Irwin, JD
    Senior Managing Consultant, Berkeley Research Group (BRG); Former Judicial Law Clerk, The Supreme Court of Pennsylvania; Washington, DC
    Denis Jacob, MBA
    Vice President, Deputy Chief Compliance Officer, Orthofix; Former Director, Ethics & Compliance, International, BD; Lewisville, TX
    James Jacobson, JD
    Senior Data Privacy Counsel and Chief Privacy Officer, U.S, Merck KGaA, Darmstadt, Germany

    Michael Joachim, JD
    Head of Ethics & Business Integrity, Specialty Care, Sanofi Genzyme, Cambridge, MA
    Elizabeth Jobes, JD
    Global Chief Compliance Officer Amryt Pharma; Former Senior Vice President, Chief Compliance Officer North America at EMD Serono Inc.; Former Head of Corporate Compliance and Legal Counsel Company, Spark Therapeutics, Inc.; Cambridge, MA
    Catherine Healy Kanzler
    Executive Director, Global Compliance Operations, Olympus Corporation of the Americas, Center Valley, PA
    Ben Kaye-Smith
    Senior Vice President Ethics, Risk & Compliance, Novartis Gene Therapies; Former Global Head Integrity & Compliance Risk Review & Prevention, Novartis; Switzerland
    Jonathon L. Kellerman
    Executive Advisor, Office of Ethics & Compliance, Abbvie; Former Executive Vice President, Global Chief Compliance Officer, Allergan, Former Partner, PwC; Madison, NJ

    Andrea L. Kocharyan, JD
    Vice President, Legal and US Chief Compliance Officer, Zealand US; Former VP, Head of Legal Affairs, Sumitomo Dainippon Oncology; Former VP, US General Counsel & Compliance Officer, EVO Biologics; Cambridge, MA
    Keith Korenchuk, MPH, JD
    Vice President and Chief Compliance Officer, DH Diagnostics, a Danaher Company, Chevy Chase, MD
    Kirt Kraeuter, MGA
    Senior Director, Corporate Compliance, Moderna; Former European Compliance Director, Otsuka; Former, Executive Director, Worldwide Compliance Committee & Monitoring, Bristol-Myers Squibb; Yardley, PA
    Daryl Kreml, JD
    Vice President, Chief Compliance Officer and Investigations Counsel, Sage Therapeutics; Former Head, US Compliance & Global Program Management, Biogen; Former Director & Senior Managing Counsel, Int’l Compliance, Boston Scientific; Cambridge, MA
    David Lazarus, JD
    Assistant United States Attorney and Unit Chief, US Attorney's Office, District of Massachusetts, US Department of Justice; Former Assistant District Attorney, Bronx District Attorney's Office; Boston, MA

    Nancy Libin, JD
    Partner and Co-Chair, Privacy & Security, and Technology Practice, Davis Wright Tremaine LLP; Former Chief Privacy and Civil Liberties Officer, US Department of Justice; Washington, DC
    Kari K. Loeser, JD
    Senior Corporate Counsel & U.S. Healthcare Compliance Officer, Relypsa, Inc; Former Investigator, U.S. Department of Health & Human Services; Former, Policy Analyst, American Medical Association; Redwood City, CA
    David J. Ludlow, JD
    Partner, Sidley Austin LLP, Washington, DC
    Joshua Marks, JD
    Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim; Former Executive Division Counsel, Corporate Compliance Officer & Asst. Secretary, Ben Venue Laboratories; Ridgefield, CT
    Jill Mason, JD
    Chief Ethics and Compliance Officer, Orthofix; Former Senior Global Compliance Director, St. Jude Medical; Lewisville, TX

    Jane Mathews, LLM, JD
    Vice President and Chief Compliance Officer, Lexicon; Former Assistant General Counsel, Sunovion; Former Senior Counsel-Managing Attorney - Head of Litigation, Hoffmann-La Roche; Ringwood, NJ
    Heather McCollum, JD, MHA, CCEP-I
    Senior Director, Compliance, Shionogi, Florham Park, NJ
    Jennifer McGee, JD
    Vice President and Global Chief Compliance Officer, Otsuka America Pharmaceutical, Rockville, MD
    Kathleen McGovern, JD
    Global Investigator, Healthcare & Crisis Management Advisor, EY; Former Senior Deputy Chief, Fraud Section, US Department of Justice; Washington, DC
    Jenny McVey, MS, PHD
    Compliance Risk Strategy & Management, Novo Nordisk, Compliance Lead, Hands International, Editorial Board Member, Policy & Medicine Compliance Update, Princeton, NJ

    Rore Middleton, JD
    Senior Director, Compliance and Privacy, Blueprint Medicines; Former Director, US Compliance and Ethics, Alexion Pharmaceuticals, Inc.; Cambridge, MA
    Gary C. Messplay, JD
    Partner, FDA and Life Sciences, King & Spalding, Washington, DC
    Lauren Miller, JD
    Corporate Counsel, Otsuka Pharmaceutical Company; Former Regulatory Counsel, Office of Prescription Drug Promotion, FDA; Washington, DC
    Vahan Minassian, JD
    Director, US Promotional Monitoring Lead, Pfizer, Philadelphia, PA
    Patrick Mooty, JD
    Executive Director, Compliance & Ethics, Sumitomo Dainippon Pharma America, Marlborough, MA

    Craig Moran, JD
    Senior Investigations Counsel, Stryker, Mahwah, NJ
    Gregory S. Moss, LLB
    Executive Vice President, General Counsel and Corporate Secretary, Chief Compliance Officer, Kadmon Holdings, New York, NY
    Kristine Mueller, JD, LLM
    Global Compliance Operations Manager, North America, Arthrex, Naples, FL
    Kristin Mykulak, JD
    Assistant General Counsel, Litigation & Compliance, Dr. Reddy's Laboratories, Princeton, NJ
    Clint Narver, JD
    Assistant Director of the Consumer Protection Branch, US Department of Justice; Former Associate Chief Counsel, US Food and Drug Administration; Washington, DC

    Gina Nese
    Chief Compliance Officer Advanced Sterilization Products (Fortive/ASP), Everett, WA
    Katie Norris, MPA
    Director, West Coast Leader, Life Sciences Governance, Risk Management and Compliance, Guidehouse; Former Senior Director, Compliance & Integrity Programs, NSF Health Sciences; San Francisco, CA
    Daniel O'Connor
    Senior Vice President, PharmaCertify, New York, NY
    John Patrick Oroho, JD
    Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman, Morristown, NJ
    Raj D. Pai, JD
    Partner, Sidley Austin LLP; Former Attorney, Office of Chief Counsel, US Food and Drug Administration; Washington, DC

    Amy Pawloski
    President, Strategic Versatility; Former Global Compliance Operations Officer, Endo; Phoenixville, PA
    Veleka Peeples-Dyer, JD
    Partner and Chair, North America Food and Drug, Administration (FDA) Practice Group, Baker & McKenzie LLP, Washington, DC
    Brad Powers, JD
    General Counsel and Chief Compliance Officer, Lumos Pharma; Former General Counsel and Chief Compliance Officer, Office of the CEO, NewLink Genetics; Des Moines, IA
    Ariadna Quesada, MPP, MSJ
    Compliance Director International EMEA, Hillrom; Former Ethics and Compliance Officer, The Netherlands, AbbVie; Former Compliance Director International, DaVita Kidney Care; Amsterdam, Netherlands
    Arjun Rajaratnam, JD
    President, Extrel Therapeutics, Inc.; Former, Chief Compliance Officer, Smith & Nephew; Raleigh, NC

    Timothy Roberts, MSJ
    Executive Director, Compliance, AbbVie; Former Executive Director, Commercial Compliance -US Medical Aesthetics, Allergan; Budd Lake, NJ
    John Seungjoo Rah, JD
    Partner, DLA Piper, Washington, DC
    Kristin Rand, JD, MA
    Head, Corporate Compliance and Global Risk Officer, Moderna, Boston, MA
    Chapman Richardson
    Global Head, Data Consumerization, Sanofi; Former Executive Director, Global Next, Generation Digital, Novartis; Bridgewater NJ
    Tim Robinson, JD, LLM
    Chief Legal and Data Privacy Officer, MediSpend, Hampton Falls, NH

    Russell Rose, JD
    Senior Manager, Deloitte & Touche, LLP, Dallas, TX
    Kevin Ryan, MS, JD
    Vice President, Chief Compliance Officer, ACADIA; Former Director, Ethics & Compliance, Novo Nordisk; San Diego, CA
    Jennifer Santos, JD
    Senior Director, R&D Business Partner, Office of Business Integrity & Ethics, Vertex Pharmaceuticals, Boston, MA
    James Sheehan, JD
    Chief, Charities Bureau at Attorney General of New York; Former Chief Integrity Officer, Executive Deputy Commissioner, City of New York Human Resources Administration; Former NY Medicaid Inspector General; Former Associate United States Attorney, US Attorney’s Office for the Eastern District of Pennsylvania; New York, NY
    Tara R. Shewchuk, JD, LLM
    Vice President & Deputy, Office of Ethics & Compliance , Medtronic Americas; Former Senior Director, Ethics and Compliance; AbbVie Minneapolis, MN

    Eric Siegel, MBA, JD
    Vice President, Head of Compliance US, Idorsia Pharmaceuticals US Inc.; Former Chief Compliance Officer, Jazz Pharmaceuticals; Former Senior Investigator, Office of the Inspector General, City of Philadelphia; Philadelphia, PA
    Paul Silver
    Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA
    Laura Skinner, MBA
    Director, Life Sciences Consulting Group Paul Hastings LLP, Austin TX
    Jon Smollen, MA, JD
    Practice Professor of Law and Executive Director, Center for Compliance and Ethics, Beasley School of Law, Temple University; Board of Directors, Astellas Pharma, US; Former Executive Vice President and Chief Compliance Officer, Endo; Philadelphia, PA
    Alexis Stroud, CQA, CCEP
    Director, Ethics & Compliance: Auditing, Monitoring, and Risk Assessment, Boehringer Ingelheim, President, Fairfield County, CT Chapter, Healthcare Businesswomen’s Association, Stamford, CT

    Carol B. Stubblefield, JD, LLM
    Partner, Baker & McKenzie LLP, New York, NY
    Tiffany Tang
    Associate Principal, Global Compliance Consulting, IQVIA; Former Senior Manager, Ethics and Compliance, Novo Nordisk; New York, NY
    Jack Tanselle, MBA
    Managing Director, Deloitte & Touche LLP, Indianapolis, IN
    Melissa Tearney, JD
    Partner and Co-chair, Litigation Department, Choate, Hall & Stewart, Boston, MA
    Scott A. Thompson
    Associate Regional Director, United States Securities and Exchange Commission, Philadelphia Regional Office, Philadelphia, PA

    Bryan Timer, MA
    Director, Data Analytics & Transparency, Merck and Co, Inc., Kenilworth, NJ
    Natasha Trifun, JD
    Executive Director, R&D, Quality, Operations, External Funding and Global Medical Compliance, Alexion; Former Brazil Compliance Officer, Pfizer; Boston, MA
    Manny Tzavlakis
    Managing Partner, Helio Health Group, Editorial Board, Policy & Medicine Compliance Update (formerly LSCU), Morristown, NJ
    Jami Vibbert, JD
    Partner, Arnold&Porter, New York, NY
    Elizabeth Weiss, JD
    Assistant General Counsel, Pfizer; Former Research Chemist, Ortho Clinical Diagnostics; Peapack, NJ

    Caroline H. West, JD
    Global Chief Compliance Officer, Olympus Corporation; Former Senior Vice President, Chief Compliance and Risk Officer, Shire; Philadelphia, PA
    Seth B. Whitelaw, JD, LLM, SJD
    President and Chief Executive Officer, Whitelaw Compliance Group, LLC; Editor, Life Science Compliance Update; Senior Fellow & Adjunct Professor, Life Sciences Compliance, Mitchell Hamline School of Law; West Chester, PA
    Catherine Williams. JD
    Director & Privacy Counsel, Privacy Office Novo Nordisk, Plainsboro, NJ
    Amy Yuda, MSJ, CCEP, CHC, CQA
    Compliance Manager, bioMerieux; Former Compliance Officer, PolarityTE; Former Compliance Officer, US WorldMeds; Salt Lake City, UT

    2020-2021 GLOBAL PHARMA/MED DEVICE ETHICS & COMPLIANCE CONGRESSES

    VIRTUAL TWENTY-FIRST ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
    Virtual Online Video Event Live and Archived
    Sponsored by Pharmaceutical Compliance Forum
    Media Partners: Harvard Health Policy Review, Health Affairs and Policy & Medicine Compliance Update
    November 4 - 6, 2020
    www.PharmaCongress.com
    VIRTUAL FOURTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE ETHICS & COMPLIANCE CONGRESS
    Virtual Online Video Event Live and Archived
    Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
    Media Partner: Policy & Medicine Compliance Update
    March 1 - 4, 2021
    www.International PharmaCongress.com

    CONTENT PURCHASING INFORMATION

    Choose from the following purchase options:

    • Online Archive with conference content (for entire conference or individual presentations)
    • Flash drive with conference content


    CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
    For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.